Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:38 pm Purchase | 2024-09-30 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM | SECTORAL ASSET MANAGEMENT INC | 950,886 5.000% | 950,886 (New Position) | Filing History |
| 2024-10-31 12:46 pm Purchase | 2024-09-30 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM | FRANKLIN RESOURCES INC BEN | 1,447,550 7.600% | 1,447,550 (New Position) | Filing History |
| 2024-04-15 4:38 pm Purchase | 2024-04-05 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM | SUVRETTA CAPITAL MANAGEMENT, LLC | 1,720,000 9.300% | 1,720,000 (New Position) | Filing History |
| 2024-04-15 4:20 pm Purchase | 2024-04-09 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM | Perceptive Advisors LLC | 1,566,669 8.500% | 1,566,669 (New Position) | Filing History |
| 2024-04-10 5:12 pm Purchase | 2024-04-09 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM | JOHNSON & JOHNSON JNJ | 1,979,173 10.700% | 1,979,173 (New Position) | Filing History |